In the present study, we collected follow-up data from a cohort of 104 newborns, in whom we have previously shown inverse associations between body size and endotheliumdependent vasodilatation. We performed these measurements in the forearm skin in the first week of life using laser Doppler flowmetry and iontophoresis of acetylcholine, an endotheliumdependent vasodilator. 12 Data obtained by this technique are associated with markers of systemic endothelial function, 13 are strongly correlated with flow-mediated dilatation of the brachial artery, 14 and are linked to coronary microvascular function 15 in adults. The primary aim of the present study was to examine whether there is an association between (critical windows of) infant growth and endothelium-dependent vasodilatation already in the first 6 months of life in healthy term infants. Second, we examined whether body size at birth or early postnatal growth is more important in the development of endothelium-dependent vasodilatation in the first 6 months of life.
Methods
An extended Methods section is available in the online-only Data Supplement.
Subjects
As described previously in detail, 12 from January 2006 to May 2010, healthy term newborns (gestational age 37-42 weeks) born at Maastricht University Medical Center who remained at the hospital for ≥3 days, could participate in the study.
Measurements

Endothelium-Dependent Vasodilatation
Measurements were performed in the first week of life and at the age of 6 months. Local microvascular skin blood flow was measured in perfusion units (PU) on the dorsal side of the forearm. These data were obtained by use of single-point laser Doppler flowmetry (Periflux System, Perimed AB, Sweden), before and after pharmacologically induced vasodilatation. Endothelium-dependent vasodilatation was induced by acetylcholine, and endothelium-independent vasodilatation was induced by nitroprusside. Administration of both drugs across the skin was realized by iontophoresis. The study protocol prescribed multiple successive doses resulting in a cumulative dose-response curve. For statistical analysis, the average perfusion values in a steady period of ≥30 seconds without significant movement artifacts were taken at baseline and at maximum attained perfusion.
Anthropometry
Birth weight was collected from the clinical records after it was measured on an electronic scale (accurate to 1 g) as part of the usual delivery protocol in our hospital. All other anthropometry was performed by 2 experienced researchers. All data points were converted into SD scores (Z scores), using reference data accurate to 1 day. Furthermore, we collected growth data (weight, length, and head circumference) from the infant and child welfare centers and extracted the measurements closest to 30 days (1 month) and 90 days (3 months).
Covariates
The following variables were collected from hospital records: sex, 16, 17 gestational age, 18 maternal hypertension during pregnancy, 17 gestational diabetes, 19 and mode of delivery. 20 Assisted pregnancy and parity were also considered potentially important, as was blood pressure of the infant. Blood pressure was measured on the arm using an automated blood pressure recorder shortly before or after assessment of vasodilatation, when the infant was quiet or asleep. Measurements were taken by an experienced researcher, with the newborn in the supine position or when held by one of the parents, using an arm circumference-adjusted cuff. Systolic, diastolic, and mean arterial blood pressures were recorded as mean of 2 measurements.
Parents were interviewed with regard to maternal smoking during pregnancy, 21 breast feeding, 22 parental ethnic background, level of education, and family history of cardiovascular disease. Level of education was expressed dichotomously, and family history of cardiovascular disease was analyzed in 4 groups. We always included the time point (either birth or 6 months) as a covariate in our analyses.
Statistical Analysis
To compare group means, the dependent t test was used. Multilevel linear regression with an unstructured covariance matrix describing the covariance between the 2 time points was used to assess the associations among growth, covariates, and vasodilatation. First, all variables were tested separately in a basic analysis with maximum perfusion as the outcome variable and sex, time point, and baseline perfusion as covariates. Because we showed their importance previously, hypertension during pregnancy was included in the acetylcholine basic model, and gestational age was added to the nitroprusside basic model. 12 Second, the variables with P<0.10 from the basic model were added to the basic birth size and growth models to create multivariable models. Third, the growth parameters that showed a P value <0.10 in the multivariable model when considered over the 0 to 6 months period were studied in more detail by decomposing growth into 3 age windows: 0 to 1, 1 to 3, and 3 to 6 months. These subwindows were tested separately and finally simultaneously to assess their relative importance. A 2 sided P value of <0.05 was considered significant, and a P value of <0.10 was considered a trend.
Results
Baseline Characteristics
From all 104 newborns included in the study, 90 attended the follow-up visit at the age of 6 months. We experienced technical problems during 3 of these 90 measurements, and 1 nitroprusside protocol could not be performed successfully. This yielded a total of 87 and 86 successful protocols of acetylcholine and nitroprusside, respectively. At birth, there were 102 and 94 successful measurements of acetylcholine and nitroprusside, respectively. The reason for the lower number of successful nitroprusside protocols at birth was that acquiring an acetylcholine measurement (always performed first) had sometimes taken too long for the newborn or the parents. The 90 infants who returned for a second visit did not differ from the 14 infants who were not measured for all birth, pregnancy, and general covariates, except for maternal educational level and maternal weight (both lower in the missing group). Maternal education level and weight were not related (P>0.90). To account for these differences, we additionally added maternal education level and maternal weight as a covariate to all multivariable models, when these variables were not included already. In Table S1 in the online-only Data Supplement, the characteristics of all infants of whom vascular measurements were available from the second time point of our study (6 months) are shown. When the data from Table S1 were statistically tested, there was no difference in baseline perfusion between the acetylcholine and the nitroprusside protocols at birth and the age of 6 months (P=0.34 12 and P=0.55, respectively). At birth, maximum perfusion in response to acetylcholine was significantly lower than maximum perfusion in response to nitroprusside (69.8 PU versus 127.6 PU; P<0.0001) perfusion in response to acetylcholine (endothelium-dependent vasodilatation) was higher at the age of 6 months than at birth (P<0.0001), whereas maximum perfusion in response to nitroprusside (endothelium-independent vasodilatation) was similar at both ages (P=0.89). The exact age of measurement at birth did not influence vascular measurements in our sample, 12 and exact age of measurement (in days) was not associated with maximum response to acetylcholine or nitroprusside in linear regression analysis (P=0.83 and P=0.35, respectively). Therefore, all measurements were regarded as measurements at either 0 or 6 months. In a total of 95 infants (91%), growth data from the infant and child welfare centers were retrieved. Within these 95 infants, the availability of growth data varied from 100% (weight at 3 months) to 83% (head circumference at 1 month).
Acetylcholine (Endothelium-Dependent Vasodilatation)
Maximum skin perfusion in response to acetylcholine at the age of 6 months was positively associated with all measures of size at birth, except weight-for-length Z score, in both the basic and the multivariable analyses (Table 1) . However, none of these birth sizes, when included in the appropriate multivariable models for growth, remained significantly associated with maximum skin perfusion in response to acetylcholine at the age of 6 months: birth weight b=0. When growth in weight and in weight relative to length was investigated in detail, we found that weight growth from 0 to 1 and from 1 to 3 months was associated with maximum perfusion after stimulation with acetylcholine, whereas weight growth from 3 to 6 months was not (Table 2) . With regard to weight-for-length, only growth from 0 to 1 month showed a relationship with maximum perfusion. To determine which of the 3 subwindows of growth in weight and weight-for-length (0-1, 1-3 , or 3-6 months) was most important, they were also tested simultaneously (Table 2 ). Weight growth from 0 to 1 month was the only subwindow significantly associated with maximum perfusion in response to acetylcholine (b=−11.72; P=0.01), and analogously weight-for-length growth from 0 to 1 month was solely associated with maximum perfusion (b=−9.45; P=0.03). Next, in a separate analysis, all SGA infants (birth weight <p10; n=27) were excluded from these final models. The results were similar, although nonsignificant for weight-for-length, despite a drop in number of participants in the model (b=−14.72; P=0.009 and b=−10.40; P=0.052 for weight and weight-for-length, respectively).
Nitroprusside (Endothelium-Independent Vasodilatation)
Maximum skin perfusion in response to nitroprusside was not associated with any of the birth or growth parameters in the basic or the multivariable analysis (Table 1) , it was, however, positively related to paternal education level (low versus high level; b=−18.34; P=0.01).
Discussion
This prospective study showed that infant growth in weight was negatively associated with endothelium-dependent vasodilatation, already at the age of 6 months, independent of birth weight. More specifically, growth in weight (and weight-forlength) during the first month of life seemed to be of pivotal importance for the early development of endothelium-dependent vasodilatation.
The results from the present study are consistent with the finding that early postnatal growth (during the first 2 weeks of life) was associated with adolescent endothelial function in individuals born preterm. 6 Moreover, we have shown a similar association at a much younger age and, notably, that the association is also present in healthy infants, born at term. In addition, we confirmed that the association between infant growth and endothelium-dependent vasodilatation is not confined to SGA infants but extends to appropriate-for-gestationalage infants. 6 The latter emphasizes that even growth in the spectrum of a normal population may have negative effects on endothelium-dependent vasodilatation. It should also be noted that, in separate models, growth consistently showed a negative influence, in both an age period in which the infants Basic model acetylcholine was adjusted for baseline perfusion, time point, sex, and hypertension during pregnancy. Multivariable model acetylcholine included the basic model also adjusted for maternal education level, paternal education level, and maternal weight. Basic model nitroprusside was adjusted for baseline perfusion, time point, sex, and gestational age. Multivariable model nitroprusside included the basic model also adjusted for maternal education level, paternal education level, ethnic background, family history of cardiovascular disease, maternal weight, and paternal height.
*Growth parameters were always additionally adjusted for baseline value; so weight (ΔZ score 0-6) was adjusted for weight Z score at birth. †There was a trend for a difference between the second lowest group (group 1) and the highest group: group 1 vs highest b=−20.23, P=0.09.
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showed slow growth (0-1 month) and in a period in which they showed faster growth (1-3 months). A beneficial effect of breast feeding (which is associated with slower postnatal growth than formula feeding during the first months of life), 23 as suggested by earlier work, 22 could not be demonstrated in our study. This might be a consequence of our moderate sample size. Finally, our data underline the importance of an early critical growth window by a direct statistical comparison of the importance of the early age window (0-1 month) with that of later age windows (1-3 and 3-6 months).
The finding of such an early effect of growth on endotheliumdependent vasodilatation further stresses that fast infant growth is not necessarily optimal growth in the long term. 24 Our study therefore emphasizes the potential of early parental counseling and of interventions regarding infant growth. In addition, the fact that an effect of growth on endothelium-dependent vasodilatation is now shown so early in life also implies that there may be a large age window (6 months to adolescence) in which individuals with accelerated growth in the first month of life may benefit from (lifestyle) advice regarding their possibly increased risk for endothelial dysfunction. This advice may be composed of many different aspects. For example, in adults, exercise 25 has a favorable effect on endothelial function. In turn, improvement of endothelial function is associated with an improvement in cardiovascular prognosis. 26 Although there is no concrete evidence for a mechanism behind the observed association between accelerated growth and endothelial function specifically, there are several hypotheses. Accelerated infant growth, at least postnatal overfeeding, may exert its effect by impacting on the hypothalamus-pituitary-adrenal axis, the growth hormone-insulin-like growth factor axis, or on appetite hormones like leptin, as reviewed by Guilloteau et al. 27 There is also a possible role for epigenetic modifications, which have been shown to occur after postweaning diet changes in mice. 28 Alternatively, and focusing on endothelial function, one could speculate that endothelial dysfunction acts as a defense mechanism to protect the infant from the adverse effects of even faster growth, because endothelial dysfunction may lead to decreased nutrient and oxygen supply to the growing tissues. Another possibility is that the endothelium is not able to adapt to the sudden rise in circulating blood volume accompanying fast growth and experiences permanent alterations in function. Finally, accelerated growth promotes adipocyte size in mice, 29 which may increase the production of adipokines, which are detrimental to endothelial function, such as leptin and resistin, although adiponectin may have beneficial effects. 30, 31 The present study describes the natural development of vascular function, namely a significant increase in endotheliumdependent vasodilatation from birth to 6 months and a steady endothelium-independent vasodilatation. With regard to the development of endothelial function, our data support a role for postnatal growth, rather than birth size, because the effects of birth size were diminished in the statistical models incorporating postnatal growth. The strong tendency of SGA infants to show accelerated postnatal growth 32 has been proposed as an explanation 3 for the identification of associations between birth weight and endothelial function in 9-year olds, adolescents, and adults. 6, 33, 34 However, this poses a problem because SGA newborns already show signs of endothelial dysfunction at birth. 12, 35, 36 Apparently, slow intrauterine growth and fast postnatal growth may both be linked to impaired endothelial function later in life. It is possible that accelerated postnatal growth is a second hit, which adds to an already existing excess risk in SGA infants. We suggest that this second hit is more powerful than the effect of being SGA. This view is supported by our finding that birth weight was negatively associated with endothelium-dependent vasodilatation at 6 months when its effect was tested separately from growth but not in simultaneous analysis with growth. Because growth and birth weight are closely related, growth may override the effect of birth weight in statistical testing when its effect is more powerful. In line with our observations, the study by Singhal et al 6 also showed a significant influence of birth weight on endothelial function at the age of 16 years, when growth was not included in the model. A multihit hypothesis for the development of cardiovascular and renal diseases has been proposed earlier, the first hit being low birth weight and the second hit being, for example, rapid weight gain. 37 Our study has several distinctive features in the field, the first being a prospective study that has taken many potential confounding factors into account. Second, our results can Models were adjusted for baseline perfusion, time point, sex, hypertension during pregnancy, maternal education level, paternal education level, and maternal weight. SGA indicates small for gestational age (<p10 for birth weight).
*Change scores were always additionally adjusted for baseline value; so weight (ΔZ score 0-6) was adjusted for weight Z score at birth.
by guest on October 13, 2017 http://hyper.ahajournals.org/ Downloaded from be extrapolated to the general population to a high degree because of the healthy, term study population. However, our sample was recruited in an academic hospital and, for example, had a higher rate of cesarean sections than the general population. Third, we showed that the observed associations regarding infant growth were absent when an endotheliumindependent vasodilator was used. This suggests that we found an exclusive association with endothelium-dependent vasodilatation and that this association was not influenced by the technique used. As an exception, we did observe an association between paternal educational level and endotheliumindependent vasodilatation; however, because we do not have a plausible biological explanation for this, we expect it to reflect a type 1 error. Our study also has several limitations. As in any observational study, no conclusions can be drawn with regard to causality. Second, because of the modest study size, we were not able to explore potentially important interactions between growth and other variables. Third, we used laser Doppler flowmetry of the forearm skin to assess endothelial function because this is the most feasible technique for use in newborns and infants. Although endothelial dysfunction measured in the skin vasculature correlates well with cardiovascular disease risk in adults 38 and endothelial dysfunction is thought to be a sensitive early marker in adolescence associated with an adverse later cardiovascular phenotype, 9 we cannot be sure what the exact meaning of endothelium-dependent vasodilatation at this young age is and whether the observed associations will track into adulthood. Also, although peripheral vascular endothelial dysfunction is thought to play a role in hypertension and diabetes mellitus, at least in adult obesity, 39 the association between our peripheral vascular measure and endothelial dysfunction in the conduit arteries (the main site of atherosclerosis) in infants is unknown. Finally, we have only studied infant growth, whereas it is clear that childhood growth may also have important effects on later cardiovascular health. 40 
Perspectives
We have shown in a prospective study that growth in the first month of life is inversely associated with endotheliumdependent vasodilatation at the age of 6 months in healthy infants born at term, regardless of SGA or appropriate-forgestational-age condition at birth. Birth size was not important when considered simultaneously with infant growth. These data underline the potential of counseling and intervening in early infant growth to prevent later cardiovascular disease and these data open up a new window (6 months to adolescence) in which a health benefit may be achieved with regard to endothelial function.
